Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 2,812 Ptc Therapeutics, Inc. shares (Form 4)

Traded May 15, 2026 · Filed May 19, 2026

On May 15, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 2,812 Ptc Therapeutics, Inc. shares at an average US$72.18 for US$203K under a trading plan, leaving 105,212 shares. Filed May 19, 2026 (Form 4).

Sold
2,812 shares
Price
US$72.18 average (US$72.08 to US$72.67)
Value
US$203K
Holding after
105,212 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 15, 2026Common StockOption exercise2,812US$25.69108,024Direct
May 15, 2026Common StockSale2,356US$72.08105,668Direct
May 15, 2026Common StockSale456US$72.67105,212Direct

Source

View original at SEC

Related